SNDX News - Candlesense

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on Augu...

Is there any risk that the newly granted shares could be used to facilitate a takeover or shareholder activism? Could the induced shares be used for future financing or acquisition purposes? How does this compensation grant compare with similar biotech companies' recent equity incentive programs?

Compensation

17 days ago